Clover Corporation Ltd
ASX:CLV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Clover Corporation Ltd
Cash from Operating Activities
Clover Corporation Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Clover Corporation Ltd
ASX:CLV
|
Cash from Operating Activities
AU$4.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
5%
|
|
|
Hazer Group Ltd
ASX:HZR
|
Cash from Operating Activities
-AU$4m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Titomic Ltd
ASX:TTT
|
Cash from Operating Activities
-AU$23.7m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
First Graphene Ltd
ASX:FGR
|
Cash from Operating Activities
-AU$1.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
18%
|
CAGR 10-Years
6%
|
|
|
Advance ZincTek Ltd
ASX:ANO
|
Cash from Operating Activities
-AU$4k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
35%
|
|
|
Foresta Group Holdings Ltd
ASX:FGH
|
Cash from Operating Activities
-AU$6m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-66%
|
CAGR 10-Years
-12%
|
|
Clover Corporation Ltd
Glance View
Clover Corp. Ltd. is engaged in research and product development of food supplements, pharmaceutical and nutraceuticals. The company is headquartered in Melbourne, Victoria and currently employs 53 full-time employees. The Company’s geographical segments include Australia/New Zealand, Asia, Europe and America. The firm is also engaged in the production of encapsulated powders, and the research and product development of functional food and infant nutrition ingredients. The company focuses on developing nutrients for use in foods or as nutritional supplements. The firm provides lipid-based ingredients for the food industry. The company focuses on the delivery of bioactive ingredients using encapsulation technology to produce ready-to-blend products containing tuna oil and other nutritional lipids. The company uses tuna oil, which has docosahexaenoic acid (DHA) for brain, nerve and eye tissue development in babies and infants. The company has a technology license for the encapsulation of marine and algal oils. The firm has a manufacturing plant for tuna oils and related products in Altona, Victoria.
See Also
What is Clover Corporation Ltd's Cash from Operating Activities?
Cash from Operating Activities
4.5m
AUD
Based on the financial report for Jan 31, 2026, Clover Corporation Ltd's Cash from Operating Activities amounts to 4.5m AUD.
What is Clover Corporation Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
5%
Over the last year, the Cash from Operating Activities growth was -78%. The average annual Cash from Operating Activities growth rates for Clover Corporation Ltd have been 2% over the past three years , -23% over the past five years , and 5% over the past ten years .
